Haptotactic migration induced by midkine. Involvement of protein-tyrosine phosphatase zeta. Mitogen-activated protein kinase, and phosphatidylinositol 3-kinase

J Biol Chem. 2001 May 11;276(19):15868-75. doi: 10.1074/jbc.m005911200.

Abstract

Midkine, a heparin-binding growth factor, plays a critical role in cell migration causing suppression of neointima formation in midkine-deficient mice. Here we have determined the molecules essential for midkine-induced migration. Midkine induced haptotaxis of osteoblast-like cells, which was abrogated by the soluble form of midkine or pleiotrophin, a midkine-homologous protein. Chondroitin sulfate B, E, chondroitinase ABC, B, and orthovanadate, an inhibitor of protein-tyrosine phosphatase, suppressed the migration. Supporting these data, the cells examined expressed PTPzeta, a receptor-type protein-tyrosine phosphatase that exhibits high affinity to both midkine and pleiotrophin and harbors chondroitin sulfate chains. Furthermore, strong synergism between midkine and platelet-derived growth factor in migration was detected. The use of specific inhibitors demonstrated that mitogen-activated protein (MAP) kinase and protein-tyrosine phosphatase were involved in midkine-induced haptotaxis but not PDGF-induced chemotaxis, whereas phosphatidylinositol 3 (PI3)-kinase and protein kinase C were involved in both functions. Midkine activated both PI3-kinase and MAP kinases, the latter activation was blocked by a PI3-kinase inhibitor. Midkine further recruited PTPzeta and PI3-kinase. These results indicate that PTPzeta and concerted signaling involving PI3-kinase and MAP kinase are required for midkine-induced migration and demonstrate for the first time the synergism between midkine and platelet-derived growth factor in cell migration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Brain / metabolism*
  • Carrier Proteins / pharmacology*
  • Cell Line
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Cells, Cultured
  • Chondroitinases and Chondroitin Lyases / metabolism
  • Collagen / pharmacology
  • Cytokines / pharmacology
  • Drug Synergism
  • Enzyme Activation
  • Glycosaminoglycans / pharmacology
  • Midkine
  • Mitogen-Activated Protein Kinases / metabolism*
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / physiology
  • Phosphatidylinositol 3-Kinases / metabolism
  • Platelet-Derived Growth Factor / pharmacology*
  • Protein Tyrosine Phosphatases / metabolism*
  • Proto-Oncogene Proteins c-sis
  • Rats
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / drug effects
  • Tumor Cells, Cultured

Substances

  • Carrier Proteins
  • Cytokines
  • Glycosaminoglycans
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • pleiotrophin
  • Midkine
  • Becaplermin
  • Collagen
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinases
  • Protein Tyrosine Phosphatases
  • Ptprz1 protein, rat
  • Receptor-Like Protein Tyrosine Phosphatases, Class 5
  • Chondroitinases and Chondroitin Lyases